Virtual Event : 3 - 4 December 2024
Listed times are in Central European Time (CET)
WELCOME TO DAY ONE
SESSION 1
Chair: Amaya Viros
Marco Demaria University of Groeningen, Netherlands
"Cellular senescence and other hallmarks of aging in cancer: friends or foes?"
Q&A 13:25-13:35
Andrea Alimonti Institute of Oncology Research, Switzerland
"Pros & Cons of senescence in cancer therapy"
Q&A 13:55-14:05
Cristina Liboni Centre pour la Recherche en Biomédicine Strasbourg (CRBS), France
Proffered Paper 1: "Neutrophils promote age-induced metastasis"
Q&A 14:15-14:20
REFRESHMENT BREAK
SESSION 2
Chair: Andrea Alimonti
Maria Mittelbrunn Madrid CBM, Spain
"Age-Related Changes in T Cells: Considerations for Cancer Therapy"
Q&A 15:00-15:10
Simona Fusco San Raffaele Telethon Institute for Gene Therapy, Italy
Proffered Paper 2: "Therapy-induced senescent cells upregulate antigen processing and presentation machinery and elicit anti-tumor immunity in Acute Myeloid Leukemia"
Q&A 15:20-15:25
Andrés Hidalgo Yale University, USA
"Multifaceted neutrophils in cancer"
Q&A 15:45-15:55
SPOTLIGHT PRESENTATIONS
2 five minute Spotlight talks, from high-scoring abstracts submitted to the meeting.
FLASH TALKS - Session 1
A selection of short 3-minute flash talks from selected abstracts submitted to the meeting.
End of Day 1
Listed times are in Central European Time (CET)
WELCOME TO DAY TWO
SESSION 3
Chair: Marco Demaria
Thomas Helleday Karolinska Institutet, Sweden
"Targeting oxidative DNA repair at the crossroad of cancer and ageing"
Q&A 14:25-14:35
Amaya Viros CRUK, UK
"Adipocyte age dependent metabolic programming dictates melanoma metastatic burden and tropism"
Q&A 14:55-15:05
Frances Turrell University of Manchester, UK
Proffered Paper 3: "Age-associated microenvironmental changes highlight the role of PDGF-C in ER+ breast cancer metastatic relapse"
Q&A 15:15-15:20
FLASH TALKS - Session 2
A selection of short 3-minute flash talks from selected abstracts submitted to the meeting.
REFRESHMENT BREAK
SESSION 4
Chair: Andres Hidalgo
Manuel Colucci Institute of Oncology Research (IOR), Switzerland
Proffered Paper 4: "Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells"
Q&A 16:05-16:10
Ashani Weeraratna Johns Hopkins Bloomberg School of Public Health, USA
"Age Against The Machine: The Impact of Aging on Tumor Progression."
Q&A 16:30-16:40
Sheila Stewart Washington University School of Medicine, USA
"Age-related changes drive breast tumorigenesis"
Q&A 17:00-17:10
CONFERENCE SUMMARY
Our Scientific Programme Committee members, Andrea Alimonti, Marco Demaria, Amaya Viros and Andres Hidalgo will join together to deliver their thoughts and a summary of the meeting.